← back to search

Todd C. Lee

McGill University Health Centre · CA
Area of research
Infectious Diseases · Clinical Biochemistry
Research interest
Research interests include COVID-19 Clinical Research Studies, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing, and Long-Term Effects of COVID-19.
h-index
45
citations
8,458
works
326
NIH funding
primary concept
Medicine
email

Recent publications

Dalbavancin for Treatment of <i>Staphylococcus aureus</i> Bacteremia
JAMA 2025cited by 26position: middledoi
Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis
JAMA Internal Medicine 2025cited by 9position: lastdoi
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults
JAMA Network Open 2024cited by 71position: middledoi
<i>Pneumocystis jirovecii</i> pneumonia in people living with HIV: a review
Clinical Microbiology Reviews 2024cited by 42position: lastdoi
Amino Acid Infusion for Perioperative Functional Renal Protection: A Meta-analysis
Journal of Cardiothoracic and Vascular Anesthesia 2024cited by 30position: middledoi
Revisiting diagnostics: erythrocyte sedimentation rate and C-reactive protein: it is time to stop the zombie tests
Clinical Microbiology and Infection 2024cited by 13position: middledoi
Does Adjunctive Clindamycin Have a Role in <i>Staphylococcus aureus</i> Bacteremia? A Protocol for the Adjunctive Treatment Domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) Randomized Controlled Trial
Clinical Infectious Diseases 2024cited by 13position: middledoi
Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections
Clinical Microbiology and Infection 2024cited by 4position: middledoi
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
The Lancet Respiratory Medicine 2023cited by 123position: middledoi
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults
JAMA Network Open 2023cited by 99position: lastdoi
Propofol and survival: an updated meta-analysis of randomized clinical trials
Critical Care 2023cited by 84position: middledoi
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19
Annals of Internal Medicine 2023cited by 36position: middledoi
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial
Open Forum Infectious Diseases 2023cited by 20position: middledoi
Early Oral Antibiotic Switch in <i>Staphylococcus aureus</i> Bacteraemia: The <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol
Clinical Infectious Diseases 2023cited by 19position: middledoi
The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults
JAMA Internal Medicine 2022cited by 141position: lastdoi
The<i>Staphylococcus aureus</i>Network Adaptive Platform Trial Protocol: New Tools for an Old Foe
Clinical Infectious Diseases 2022cited by 95position: middledoi
Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV
Open Forum Infectious Diseases 2022cited by 71position: middledoi
Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults
JAMA Network Open 2022cited by 69position: middledoi
Colistin Nephrotoxicity: Meta-Analysis of Randomized Controlled Trials
Open Forum Infectious Diseases 2021cited by 86position: lastdoi
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
ERJ Open Research 2021cited by 68position: middledoi
Web and phone-based COVID-19 syndromic surveillance in Canada: A cross-sectional study
PLoS ONE 2020cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Emily G. McDonald · McGill University Health Centre6 papers (2022–2025)Brad Spellberg · University of Southern California3 papers (2022–2025)Alberto Zangrillo · Mylan (Switzerland)2 papers (2023–2024) · 2 papers (2023–2024) · 2 papers (2022–2024)Tom Boyles · Groote Schuur Hospital2 papers (2024–2024) · 2 papers (2023–2024)Giovanni Landoni · Vita-Salute San Raffaele University2 papers (2023–2024)Connor Prosty · McGill University Health Centre2 papers (2024–2025) · 2 papers (2022–2025)Matthew C. Phillips · Harvard University2 papers (2022–2024)Nathan M. Stall · Institute for Clinical Evaluative Sciences1 papers (2020–2020) · 1 papers (2025–2025) · 1 papers (2023–2023)Jimmy Ming-Yang Hsu · McGill University Health Centre1 papers (2024–2024)Zahra Sohani · McGill University Health Centre1 papers (2024–2024) · 1 papers (2023–2023)Noah Wald‐Dickler · University of Southern California1 papers (2024–2024) · 1 papers (2021–2021)Jared B. Hawkins · Boston Children's Hospital1 papers (2020–2020)